GoodRx is set to pay out $32M in settlement money. Here’s who is eligible - The Independent
Want to bookmark your favourite articles and stories to read or reference later? Start your Independent Membership today.
The clock is running out for consumers to get their share of a $32 million class-action settlement against online pharmacy and telehealth provider, GoodRx, and tech partners Criteo, Meta and Google.
Consumers who used GoodRx at any time before April 20, 2024, have until December 29 to file a claim, object to or opt out of the suit, according to the settlement’s website.
The settlement stems from GoodRx allegedly sharing “personal and health information, including information about their prescription medications and health conditions, email addresses, and phone numbers” with advertising and analytics partners Criteo, Meta and Google from at least 2017 to 2020, court documents state.
The Federal Trade Commission, which protects consumers from unfair business practices, filed a lawsuit against GoodRx and its partners on February 1, 2023, stating the information sharing violated privacy laws in California, Illinois and New York, court records note. Nearly three years later, on November 19, 2025, GoodRx agreed to a settlement but did not “admit to the allegations,” court documents show.
Registered participants in the class-action suit will receive equal shares of the settlement money after various charges, taxes and attorney fees are paid from the $32 million.
Consumers who qualify for a share of the settlement must file one of two ways: online through a form the settlement’s website provides, or mail a completed paper copy of the form to GoodRx Data Disclosure Settlement; c/o A.B. Data, Ltd.; P.O. Box 173138; Milwaukee, WI; 53217.
The deadline for online filing is 11:59 p.m. EST on December 29. All mailed-in claim forms must be postmarked by December 29, the settlement’s website says.
Files must provide a payment option for their settlement payout. Options include a prepaid virtual Visa card, paper check, PayPal, Venmo or Zelle.
Neither the settlement website nor court documents indicate how much each consumer will receive from the lawsuit.
This is the third class-action lawsuit GoodRx has faced in the past four years. The company was accused, along with other businesses, of price-fixing in a 2024 lawsuit. In 2022, investors accused GoodRx of making false or misleading statements about an influential partnership with grocery chain Kroger.

